News | News By Subject | News by Disease News By Date | Search News

Bipolar Disorder News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Neurocrine Biosciences (NBIX)'s NBI-98854 Hits Primary Enpoint in Phase III Study     10/9/2015
FDA Approves Allergan (AGN) and Gedeon Richter (RIG2.F)'s Antipsychotic Vraylar     9/18/2015
EXCLUSIVE: Moleculera Labs Will Add Close to A Dozen As It Doles Out $300K Grant     7/8/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Pfizer (PFE)'s Antipsychotic Geodon Could Cause Fatal Skin Reaction: FDA     12/15/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Tout Positive Phase 2b Bipolar Depression Data     3/31/2014
Teva Pharmaceutical Industries Limited (TEVA) to Drop Depression Treatment After Phase 3 Trial Fails     9/3/2013
Teva Pharmaceutical Industries Limited (TEVA)'s NUVIGIL® Fails Phase 3 Trial Again     1/23/2013
Forest Laboratories, Inc. (FRX) Files Schizophrenia Drug With FDA     11/28/2012
Dainippon Sumitomo Pharma Co., Ltd. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression     5/7/2012
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd.'s Cariprazine Succeeds in Third Phase III Bipolar Disorder Study     2/8/2012
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder     10/5/2011
Repligen Corporation (RGEN) Stock Plunges On Failed Bipolar Drug Study     3/8/2011

News from Around the Web
Bipolar Disorder Has Genetic Links To Autism, University of Iowa Study Suggests     5/5/2016
International Team Of Scientists Detect Inherited Traits Tied To Sleep, Wake, And Activity Cycles Associated With Severe Bipolar Disorder, UT Southwestern Medical Center Reveals     12/29/2015
Some Common Antidepressants Linked To Heightened Risk Of Mania And Bipolar Disorder, Study Published In BMJ     12/17/2015
Lower Availability Of Omega-3 Fatty Acids Linked To Bipolar Disorder, Penn State College Of Medicine Study     12/7/2015
Teens With Depression, Bipolar Disorder Should Be Screened For Heart Disease, Experts Say     8/12/2015
For Women With Bipolar Disorder, Sleep Quality Affects Mood, Penn State University Study     7/1/2015
Does Creativity Share Genetic Roots With Schizophrenia? Maybe, King's College London Study     6/9/2015
Links Between Omega-3s And Vitamin D Explored, Children's Hospital Oakland Research Institute Study     2/27/2015
Yoga May Help People With Bipolar Disorder, Brown University Survey Reveals     9/19/2014
University Hospital Bonn Scientists Locate Bipolar Disorder Gene And Gene Regions, Bringing Total Count To 5,     3/12/2014
Bipolar Patients Need Highly Targeted Treatments, University of Toledo Medical Center Study     6/14/2011
Scientists Identify Susceptibility Factor for Bipolar Disorder, University of Bonn Study     3/4/2011
Medications Used to Treat Neurologic and Psychiatric Conditions Increase Smokers’ Nicotine Metabolism, University of Medicine and Dentistry of New Jersey Study     9/20/2010
Body Clock Mouse Study Suggests New Drug Potential, Manchester Metropolitan University Study     8/24/2010
Ketamine May Relieve Depression Quickly For Those With Treatment-Resistant Bipolar Disorder, National Institute of Mental Health Study     8/3/2010

Press Releases
Otsuka Pharma Release: FDA Accepts For Review A Supplemental New Drug Application To Expand Labeling Of Abilify Maintena (Aripiprazole) For The Treatment Of Bipolar I Disorder     11/30/2016
Alexza Pharma (ALXA) Announces U.S. Approval Of ADASUVE sNDA     10/11/2016
Allergan (AGN) Announces U.S. Availability of VRAYLAR (cariprazine) For Treatment Of Bipolar Mania And Schizophrenia In Adults     3/16/2016
Sound Pharmaceuticals, Inc. And University of Oxford Collaborate On A New Treatment For Bipolar Disorder     3/9/2016
Intra-Cellular Therapies Reports Initiation Of Patient Enrollment For ITI-007 Phase 3 Clinical Trials In Bipolar Depression     12/23/2015
NeuroRx Provides Clinical Development Update For Cyclurad, A Novel Treatment For Acute Suicidal Crisis In Bipolar Disorder     12/17/2015
NeuroRx Provides Clinical Development Update For Cyclurad, A Novel Treatment For Acute Suicidal Crisis In Bipolar Disorder     12/16/2015
Intra-Cellular Therapies To Present At The 54th Annual Meeting Of The American College Of Neuropsychopharmacology     12/7/2015
The Emmes Corporation Release: Research Shows Lithium As An Effective Treatment For Pediatric Bipolar Disorder     10/27/2015
New Pilot Study Finds The Fisher Wallace Laboratories Stimulator Effective In Treating Bipolar Depression     10/9/2015
Intra-Cellular Therapies, Inc. Announces Phase III Clinical Development Program For The Treatment Of Depressive Episodes Associated With Bipolar Disorder (Bipolar Depression)     7/22/2015
Allergan (AGN) Release: SAPHRIS (asenapine) 2.5 mg Sublingual Tablets For The Acute Treatment Of Manic Or Mixed Episodes Of Bipolar I Disorder In Pediatric Patients (Ages 10-17) Now Available In Pharmacies Throughout The U.S.     7/17/2015
Cognizin Citicoline KYOWA HAKKO USA Release: Cognizin Citicoline Supplementation Effective At Reducing Cocaine Dependence in Bipolar Patients     7/7/2015
Moleculera Labs Receives Grant From OCAST To Develop Assays To Identify Individuals With Neuropsychiatric Disorders Of Autoimmune Origin     7/7/2015
NeuroRx Announces First Human Trial Results Targeting Sustained Treatment Of Bipolar Depression & Suicidality     6/24/2015

//-->